News
Hosted on MSN12mon
R1 RCM may see $15 a share in LBO; deal looks more likely nowA $15 a share takeover of RCM could generate a "healthy" ~20 IRR over a 5-year period at this level, Santagelo added. RCM is scheduled to report Q1 results next Wednesday.
Titan Health 2024 RCM Benchmark Report provides a powerful blueprint for achieving financial resilience in uncertain times In an environment where Medicaid comprises up to 54% of revenue for some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results